Latest Breaking News On - Productive drug development team - Page 1 : comparemela.com

Expands Viatris Portfolio of Innovative Assets by Immediately Adding Two Phase 3 Assets, Selatogrel and Cenerimod, Both With Blockbuster Revenue PotentialIncludes Future Optionality to Expand.

Andhra pradeshNew yorkUnited statesSouth koreaNew york universityColumbia universityScotta smithAnca askanaseJean paul clozelPhilippe martinDeepakl bhattIdorsia ltdLupus centerViatris incSwiss exchangePrnewswire viatris inc